Cargando…

MicroRNA-34a/IL-6R pathway as a potential therapeutic target for ovarian high-grade serous carcinoma

Accumulating evidence has indicated that microRNAs play a critical role in the pathogenesis of human cancers. microRNA-34a (miR-34a) has been shown to be a key regulator of tumor suppression by targeting several cancer-related signals, including the interleukin-6 receptor (IL-6R)/Signal Transducers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yokomizo, Ryo, Yanaihara, Nozomu, Yamaguchi, Noriko, Saito, Misato, Kawabata, Ayako, Takahashi, Kazuaki, Takenaka, Masataka, Yamada, Kyosuke, Shapiro, Jason Solomon, Okamoto, Aikou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690672/ https://www.ncbi.nlm.nih.gov/pubmed/31448054 http://dx.doi.org/10.18632/oncotarget.27117

Ejemplares similares

MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma
por: Yanaihara, Nozomu, et al.
Publicado: (2016)

Interleukin-6 as an enhancer of anti-angiogenic therapy for ovarian clear cell carcinoma
por: Seki, Toshiyuki, et al.
Publicado: (2021)

PIK3CA and KRAS mutations in cell free circulating DNA are useful markers for monitoring ovarian clear cell carcinoma
por: Morikawa, Asuka, et al.
Publicado: (2018)

MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma
por: Hirata, Yukihiro, et al.
Publicado: (2014)

Antenatal screening timeline and cutoff scores of the Edinburgh Postnatal Depression Scale for predicting postpartum depressive symptoms in healthy women: a prospective cohort study
por: Tanuma-Takahashi, Akiko, et al.
Publicado: (2022)

Feasibility of reduced port surgery applying Higuchi’s transverse incision
por: Ueda, Kazu, et al.
Publicado: (2017)

Somatic Copy Number Alterations Associated with Japanese or Endometriosis in Ovarian Clear Cell Adenocarcinoma
por: Okamoto, Aikou, et al.
Publicado: (2015)

Efficacy of edoxaban for the treatment of gynecological cancer-associated venous thromboembolism: analysis of Japanese real-world data
por: Odajima, Suguru, et al.
Publicado: (2022)

Treatment Strategies for ARID1A-Deficient Ovarian Clear Cell Carcinoma
por: Takahashi, Kazuaki, et al.
Publicado: (2021)

A case of relapsing aseptic meningitis under excellent tumor response to pembrolizumab in microsatellite instability-high recurrent endometrial cancer
por: Noguchi, Daito, et al.
Publicado: (2021)

Analysis of Surgical Procedure of Four Cases of Ovarian Pregnancies Treated with Laparoscopic Surgery
por: Kasahara, Yuta, et al.
Publicado: (2021)

Higuchi’s transverse incision and a modification of this method for minimally invasive surgery
por: Okamoto, Aikou, et al.
Publicado: (2017)

The Cancer Stem Cell Marker CD133 Interacts with Plakoglobin and Controls Desmoglein-2 Protein Levels
por: Koyama-Nasu, Ryo, et al.
Publicado: (2013)

Laparoscopic Surgery for Atypical Endometrial Hyperplasia with Awareness Regarding the Possibility of Endometrial Cancer
por: Kamii, Misato, et al.
Publicado: (2022)

Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference
por: Jang, Ji Yon Agnes, et al.
Publicado: (2017)

Concurrent Primary Peritoneal Low-Grade Serous Carcinoma and Endometrial High-Grade Serous Carcinoma
por: Lockyer, Megan G., et al.
Publicado: (2015)

Development and evaluation of a cervical cancer screening system in Cambodia: A collaborative project of the Cambodian Society of Gynecology and Obstetrics and Japan Society of Obstetrics and Gynecology
por: Ueda, Yutaka, et al.
Publicado: (2019)

Initiatives and achievements of the Japanese Society of Obstetrics and Gynecology, Obstetrics and Gynecology MIRAI Committee 2020
por: Komatsu, Hiroaki, et al.
Publicado: (2021)

Guidelines for Handling of Cytological Specimens in Cancer Genomic Medicine
por: Morii, Eiichi, et al.
Publicado: (2023)

Novel therapeutic strategies for injured endometrium: intrauterine transplantation of menstrual blood‑derived cells from infertile patients
por: Hosoya, Satoshi, et al.
Publicado: (2023)

Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
por: Hollis, Robert L., et al.
Publicado: (2022)

CRISPR/Cas9 Screening for Identification of Genes Required for the Growth of Ovarian Clear Cell Carcinoma Cells
por: Kawabata, Ayako, et al.
Publicado: (2022)

PHOSPHATE exporter XPR1/SLC53A1 is required for the tumorigenicity of epithelial ovarian cancer
por: Akasu‐Nagayoshi, Yoko, et al.
Publicado: (2022)

Endometrioid Adenocarcinoma with High-Grade Transformation with Serous and Choriocarcinomatous Differentiation - A Case Report
por: Wakahashi, Senn, et al.
Publicado: (2011)

Endometrial regeneration with endometrial epithelium: homologous orchestration with endometrial stroma as a feeder
por: Yokomizo, Ryo, et al.
Publicado: (2021)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Bilateral Serous Psammocarcinoma of Ovary: Rare Variant Low Grade Serous Carcinoma
por: Jena, Saubhagya Kumar, et al.
Publicado: (2015)

Long term outcomes from lymphatic venous anastomosis after total hysterectomy to prevent postoperative lymphedema in lower limb
por: Ezawa, Masahiro, et al.
Publicado: (2019)

The Continuum of Serous Tumors of Low Malignant Potential and Low-Grade Serous Carcinomas of the Ovary
por: Wong, Kwong-Kwok, et al.
Publicado: (2007)

Oncogenes in high grade serous adenocarcinoma of the ovary
por: Manasa, Pacharla, et al.
Publicado: (2020)

Smartphone application improves fertility treatment-related literacy in a large-scale virtual randomized controlled trial in Japan
por: Yokomizo, Ryo, et al.
Publicado: (2021)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Low-grade serous carcinoma with extensive osseous metaplasia arising from ovarian serous cystadenofibroma
por: Ribeiro e Ribeiro, Renan, et al.
Publicado: (2021)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

Integrative analysis reveals early epigenetic alterations in high-grade serous ovarian carcinomas
por: Machino, Hidenori, et al.
Publicado: (2023)

CT features of low grade serous carcinoma of the ovary
por: Pannu, Harpreet K.
Publicado: (2015)

Targeting the Microenvironment in High Grade Serous Ovarian Cancer
por: Nwani, Nkechiyere G., et al.
Publicado: (2018)

The Tumor Microenvironment of High Grade Serous Ovarian Cancer
por: Stack, M. Sharon, et al.
Publicado: (2018)

Cell Origins of High-Grade Serous Ovarian Cancer
por: Kim, Jaeyeon, et al.
Publicado: (2018)

Proteome profiling of low grade serous ovarian cancer
por: zadeh fakhar, Haniyeh Bashi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u5oijcq8drl9u42b9r89l47rh3